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Several human cell lines derived from primary cancer of the liver are able to grow under serum-free condi- 
tions and produce spreading and growth factors which are released into the culture medium. Since this au- 
tocrine growth under hormone-free conditions might play a basic role in malignant transformation, we stud- 
ied the effect on cell replication and the presence of specific membrane receptors of epidermal growth factor 
(EGF) and insulin on a dedifferentiated human hepatoma cell line, named HAZZT/VGH. Our results point 
to a similar inhibitory effect on cell replication in the presence of both EGF and insulin, in spite of detecting 
different affinities of binding. 
Hepatitis B virus; Insulin receptor; Epidermal growth factor receptor; (Human hepatoma cell line) 
1. INTRODUCTION 
One of the main characteristics of most human 
hepatoma-derived cell lines is their ability to grow 
in vitro under serum-free conditions [l-3]. It has 
been proposed that these autocrine systems may 
utilize ectopically produced growth factors in place 
of serum nitrogens [4]. Additionally, several cell 
lines from liver cancer were seen to produce 
spreading and attachment factors which are re- 
leased into the culture medium; these factors act 
not only on the growth of the producing cell line, 
but also on that of other hepatoma cells [5,6]. 
The autocrine growth might play a basic role in 
malignant transformation of cells [7] and 
qualitative or quantitative alterations in a growth 
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factor or in its receptor may be related to the ex- 
pression of oncogenes [g-lo]; these hypotheses 
have been explored in recent years in human 
hepatoma cell lines [ 111. 
One of the most promising aspects of the 
hepatoma transformed phenotype is the actual 
possibility of investigating the effects of different 
hormones and growth factors under fully con- 
trolled conditions [ 121. 
Here, we present data on a dedifferentiated 
human hepatoma cell line, named HA22T/VGH 
[ 131. Although expression of integrated hepatitis B 
virus (HBV) ‘S’ gene was undetectable, we showed 
by Southern-blot hybridization at least three HBV 
DNA copies integrated into the host DNA. In 
terms of growth, this line presents a significantly 
different response to the presence of epidermal 
growth factor (EGF), insulin and human growth 
hormone (hGH) in a serum-free culture medium. 
In addition, the presence of specific membrane 
receptors for EGF and insulin (and their affinity) 
was investigated. 
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2. MATERIALS AND METHODS 
2.1. Cells, cell culture and growth factors 
The HA22T/VGH cell line, derived from a 
primary hepatocellular carcinoma and received in 
September 1985, was adapted to grow in RPM1 
1640 medium supplemented with 10% fetal calf 
serum (FCS) (Gibco, Grand Island, NY) and has 
been passaged serially in our laboratory. The cells 
were also cultured in RPM1 1640 supplemented 
with 10m8 NazSeO3, in the complete absence of 
FCS. In some experiments a 1: 1 mixture (v/v) of 
RPM1 1640 and RPM1 1640 conditioned by a 48 h 
cell growth was used. Generally, Nunc (Roskilde, 
Denmark) 4 or 24-well tissue culture plates were 
used. 
Cell counts were determined using a 
hemocytometer; two to four experiments were per- 
formed for each aspect. 
EGF from mouse submaxillary glands and hGH 
from human pituitary glands were purchased from 
Sigma (St. Louis); human insulin was a gift from 
Novo (Copenhagen, Denmark). 
2.2. Hepatitis B surface antigen (HBsAg) 
detection 
The presence of HBsAg was investigated in both 
the cell cytoplasm of HA22T/VGH and the crude 
supernatants of growing and confluent cell 
cultures. 
Intracellular HBsAg kas detected by indirect im- 
munofluorescence using a rabbit anti-HBs an- 
tibody (Behringwerke, Marburg), while HBsAg 
released in culture medium was assayed by employ- 
ing commercial reagents (Ausria II, Abbott, North 
Chicago, IL), with reference to a standard curve 
determined using a purified preparation of an- 
tigen. PLC/PRF/S human hepatoma cells were 
used as positive control [14]. 
2.3. Southern-blot analysis 
Southern analysis of HindIII-digested cell DNA 
was performed according to [ 151. Briefly, the filter 
was hybridized, after Southern transfer and pre- 
hybridization, with nick-translated DNA of a 
plasmid containing head-to-tail dimer of complete 
3.2. kb HBV genomes (HBsAg subtype ayw) in- 
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Fig. 1. HBV DNA and HBsAg production by HA22T/VGH cells. (A) Southen-blot analysis of the HindIIl-digested 
DNA (a, HA22T/VGH; b, PLC/PRF/S); three bands of HBV DNA specific sequences of 23, 17 and 1.8 kb in size 
have been detected. (B). HBsAg production by growing PLC/PRF/S and HA22T/VGH cells. 5 x 10’ cells/25 cm2 flask 
were plated at time 0; amounts of antigen were detected at intervals of 24 h for 4 days. 
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serted into the EcoRI restriction site of the pBR 
plasmid [ 16-181. After hybridization, the unincor- 
porated radioactivity was washed out, and the 
filter dried and exposed to X-ray film with intensi- 
fying screens for 10 days at -80°C. 
2.4. Hormone binding 
To measure “‘1-EGF binding a previously 
described procedure with minor modification was 
applied [ 191. Cells were cultured on 4- or 24-well 
tissue culture dishes at a density of l-2 x 10’ 
cells/well; the culture medium was discarded and 
cells were rinsed three times using Hank’s balanced 
salt solution. 0.1 M Hepes buffer containing 0.5 
fig/ml 1251-EGF (2.4-3.5 x 10’ cpm/pg) was used; 
the cells were incubated for different periods and 
incubation terminated by washing the cells six 
times with PBS supplemented with 1 mg/ml bovine 
serum albumin (BSA), pH 7.0, at 4°C. Radioac- 
tivity was determined in a y-counter after treat- 
ment with 0.5 ml/well lysis buffer (0.1 M NaOH, 
2% NaCO3, 1% SDS). Incubation was performed 
at 4, 24 and 37°C; 24°C was found to be the most 
suitable temperature (not shown). 
Non-specific binding was determined in the 
presence of a 200-fold excess of unlabeled EGF 
and was less than 3% in all experiments. 
l-600pg/ml of unlabeled EGF was added to the 
binding buffer for the competition assay. 12?-EGF 
degradation during binding experiments was 
studied by precipitation in the presence of 10% 
trichloroacetic acid. 
Confluent monolayers of cells were rinsed and 
incubated with 0.1 M Hepes supplemented with 
0.04 mCi/ml ‘251-insulin for insulin binding. 24°C 
was determined to be the most suitable incubation 
temperature. Non-specific binding was determined 
in the presence of unlabeled insulin (1 mg/ml) and 
the competition curve established by adding 
unlabeled insulin (l-1000 ng/ml) to the binding 
buffer. “‘I-insulin degradation was defined by us- 
ing trichloroacetic acid precipitation. 
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Fig.2. Growth of HA22T/VGH cells under serum-free conditions. (A) Growth curves of cells cultured in RPM1 1640 
supplemented with 10% FCS (0) and RPM1 1640 supplemented with lo-’ M NazSeOj (0). Cells were plated at a den- 
sity of 5 x lo4 cells/well and counted at intervals of 24 h. Each point is the mean -t SE of four determinations. (B) 
Relationship between viable HA22T/VGH cell yield and cell inoculum in medium supplemented with 10% FCS (o), 
lo-’ M NazSeOl (0) or in a conditioned medium (see section 2) (A). 150-15 000 and 300-30000 viable cells were 
seeded in 0.2 ml of each medium in triplicate samples (96-well tissue culture dishes). Cells were counted after growth 
for 4 days. Straight lines were fitted by regression using three points (inocula from 1000 to 10000). The value beside 
each straight line indicates the slope. Each point is the mean k SE. 
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3. RESULTS 
3.1. HBV DNA integration and HBV gene 
expression 
HBsAg expression of HA22T/VGH was 
undetectable under routine culture conditions in 
both the cell cytoplasm (not shown) and culture 
medium, whereas the PLC/PRF/S cell line pro- 
duces and releases large amounts of antigen 
(fig.lB). In spite of these negative results, we 
observed after Hind111 digestion three bands of 23, 
17 and 1.8 kb size specific for HBV DNA by 
Southern hybridization, using a complete HBV 
DNA probe (fig.lA). 
medium in the presence of the trace element 
selenium (as NazSeCQ. Under these culture condi- 
tions, an initial loss of adhering cells was detected 
(fig.2A), but cell replication with a doubling time 
of 30 h (rather than 20 h for cells cultured in the 
presence of 10% FCS) was observed. The cell input 
was also related to cell release under three different 
culture conditions; regression analysis of data 
(fig.2B) shows that better attachment and growth 
can be achieved by culturing cells in a conditioned 
medium, rather than in fresh RPM1 1640. The 
regression curve for cells cultured by using a condi- 
tioned medium shows increased cell replication 
even at low densities, when compared with cells 
cultured in fresh medium. 
3.2. Ceil growth under serum-free conditions For dose-response experiments, cells were plated 
and in the presence of hormones and maintained for 24 h in a medium sup- 
The human hepatoma cell line HA22T/VGH is plemented with 10% FCS, in order to avoid the in- 
able grow in fully defined serum-free, mitogen-free itial loss of adhering cells which was observed 
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Fig.3. Dose-response curve of HA22T/VGH cells grow- 
ing in the presence of EGF (A), insulin (B) and hGH (C). 
Cells were seeded at a density of 5 x 10” cells/well, in 
medium supplemented with 10% FCS for 24 h; the 
medium was then discarded and fresh serum-free 
medium containing different amounts of hormones was 
added. Cells were counted after 5 days. Each point is the 
mean k SE of four determinations. 
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Fig.4. Reversal of EGF inhibition of HA22TlYGW cell 
growth. 4 x lo4 cells/well were plated in RPM1 1640 
medium supplemented with 10% FCS and, after 
repeated washing 24 h later, the medium was changed to 
RPM1 1640 supplemented with lo-* M NazSe03 in the 
absence or presence of lOsg/ml EGF (day 0). Each ex- 
perimental group was subdivided on day 5 (arrow) into 
two groups with the substitutions indicated. Values are 
means + SE (n = 4). 
under fully serum-free conditions. 24 h after 
plating, cells were washed three times and serum- 
free medium containing different amounts of 
EGF, insulin and hGH was added. The results (fig. 
3A,C) show that hGH induces slight stimulation 
within a narrow range, whereas strong dose- 
dependent inhibition of cell replication was 
detected in the presence of both EGF and insulin. 
The EGF-mediated inhibitory effect on cell 
replication seems to be dependent on the con- 
tinuous presence of the growth factor in the culture 
medium as shown in fig.4, because ceil replication 
is reduced in the presence of EGF, while cells grow 
normally in its absence. 
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Fig.5. EGF receptors of HA22T/VGH. (A) ‘251-EGF bound to cells cultured in 4-well tissue culture dishes incubated 
at 4°C. Cells were incubated for different periods in the presence of %EGF~ incubation was terminated by washing I 
and radioactivity determined after treatment with lysis buffer. Non-specific binding (- - - -) was determined in the 
presence of a 200-fold excess of unlabeled EGF. (B) Competition assay of unlabeled EGF. l-600 ng/ml unlabeled EGF 
was added to the binding buffer (see section 2). 
15 
Volume 221, number 1 FEBS LETTERS August 1987 
30 60 QIJ 120 150 Iv!” ;’ 5 r: 500 lOnO 
: (nq/nl) 
Fig.6. Insulin receptors of HA22T/VGH cells. (A) ‘251-insulin bound to cells incubated at 24°C. (- - - -) Non-specific 
binding determined in the presence of a 200-fold excess of unlabeled insulin. (B) Competition assay of unlabeled insulin. 
l-1000 ng/ml unlabeled hormone was added to the binding buffer. 
3.3. Hormone binding to specific membrane 
receptors 
“‘1-EGF binding at 24°C reached the maximum 
level within 30 min and this plateau was main- 
tained for more than 3 h. Non-specific activity was 
less than 3%. The specificity of the receptor was 
evaluated by increasing the doses of unlabeled 
EGF (fig. 5A,B). The highest degree of insulin 
binding was found to occur within 90 min (b/t 3%) 
and was maintained for more than 3 h. The com- 
petition curve of unlabeled insulin shows the low 
affinity of the insulin receptor of HA22T/VGH 
cells (fig. 6A,B). 
4. DISCUSSION 
EGF enhances DNA synthesis in cell culture 
[20,21] and, similarly to insulin, increases the up- 
take of glucose, amino acids and uridine [21-231, 
indicating that these hormones can regulate a 
variety of cell functions. In addition, the EGF 
receptor is a glycosylated protein [24], 
autophosphorylated through a kinase that is an in- 
tegral part of the receptor [25]. Similarly, insulin 
exherts numerous effects on the metabolism of car- 
bohydrates, lipids and amino acids, as well as on 
membrane transport processes. The insulin recep- 
tor is composed of two subunits with kinase activi- 
16 
ty; insulin binding to its receptor stimulates this 
activity and the receptor phosphorylates itself as 
well as other proteins [26]. Both hormones are in- 
volved in the regulation of cell growth [27]. 
Our data show that a dedifferentiated human 
hepatoma cell line (HA22T/VGH) has both high- 
affinity EGF receptors and low-affinity insulin 
receptors; EGF binding appears to be similar to 
those reported for most cells known to show a 
mitogenic response to EGF [28]. Nevertheless, 
similarly to insulin, EGF inhibited cell prolifera- 
tion. 
EGF was recently observed to inhibit the growth 
of a variety of carcinoma-derived cell lines [29-331; 
in addition, it was shown that the growth of a 
clone from a human hepatoma cell line (named 
LI7A) is inhibited by the presence of EGF in a 
serum-free medium 1341. It has been proposed that 
these inhibitory effects might be due to the 
presence of a large number of high-affinity mem- 
brane receptors, causing excessive kinase stimula- 
tion [35]. 
Taken together, data reported here point to the 
strong inhibition of cell replication in the presence 
of two hormones with membrane receptors of dif- 
ferent degrees of affinity, whereas only hGH ap- 
pears to be mitogenic for HA22T/VGH within a 
narrow range. In our opinion, these cells can be 
Volume 221, number 1 FEBS LETTERS August 1987 
useful as a model for elucidating mechanisms 
whereby EGF, in this case similarly to insulin, in- 
hibits the proliferation of cell lines with membrane 
receptors of different degrees of affinity. 
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